Novo Nordisk
NVO
NVO
700 hedge funds and large institutions have $9.54B invested in Novo Nordisk in 2020 Q4 according to their latest regulatory filings, with 96 funds opening new positions, 229 increasing their positions, 225 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.32% less ownership
Funds ownership: 15.38% → 15.06% (-0.32%)
2% less capital invested
Capital invested by funds: $9.68B → $9.54B (-$146M)
42% less funds holding in top 10
Funds holding in top 10: 12 → 7 (-5)
Holders
700
Holding in Top 10
7
Calls
$68M
Puts
$54.6M
Top Buyers
| 1 | +$18.5M | |
| 2 | +$18.4M | |
| 3 | +$14.4M | |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$13.9M |
| 5 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$11.7M |
Top Sellers
| 1 | -$89.4M | |
| 2 | -$49.1M | |
| 3 | -$40.5M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$31.8M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$25.9M |